Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study

Linda Williams, Paul Tiseo, Haobo Ren, Scott Mellis
  • Journal of Pain Research, August 2014, Taylor & Francis
  • DOI: 10.2147/jpr.s65974

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Haobo Ren